Danish microRNA company Exiqon said today that it has signed a development and distribution agreement with MultiD Analyses in the area of qPCR data analysis.
Under the agreement, the companies will incorporate a version of MultiD's GenEx qPCR analysis software into Exiqon's MiRcury Locked Nucleic Acid Universal RT microRNA PCR system, enabling Exiqon to offer a fully compatible and comprehensive data-analysis tool with its system.
The GenEx software has been adapted to allow "easy pre-processing and analysis of data from the Exiqon miRNA PCR panels and assays," Henrik Pfundheller, vice president of sales and marketing for Exiqon, said in a statement.
Pfundheller added that it is important that Exiqon's customers can "process, normalize, and analyze their qPCR data properly and with confidence."
Specifically, MultiD has developed a special plate design module for its software that will enable Exiqon customers to design qPCR experiments in silico and generate templates for import into their real-time PCR instruments, Mikael Kubista, chairman of MultiD, said in a statement.
The GenEx software includes features such as reference gene selection and validation, data pre-processing, and advanced statistical methods to process and analyze qPCR data.
Exiqon's miRcury LNA Universal RT microRNA PCR system uses two LNA-enhanced PCR primers that enable accurate quantification of very low miRNA levels and discrimination between closely related miRNA sequences, Exiqon said.
The product line includes miRNA ready-to-use PCR panels to conduct expression profiling of 730 human miRNAs, individual miRNA assays, reference genes, and reagent kits.
Earlier this month, Exiqon inked a deal with BioDiscovery giving Exiqon the right to include BioDiscovery's array image analysis, data analysis, and visualization software with Exiqon's miRNA arrays.